Achieve Life Sciences Inc (ACHV)
5.15
0.00 (0.00%)
USD |
NASDAQ |
May 22, 16:00
5.15
0.00 (0.00%)
After-Hours: 20:00
Achieve Life Sciences Cash from Operations (Quarterly): -5.288M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -5.288M |
| December 31, 2023 | -4.364M |
| September 30, 2023 | -5.136M |
| June 30, 2023 | -6.676M |
| March 31, 2023 | -8.303M |
| December 31, 2022 | -11.14M |
| September 30, 2022 | -11.31M |
| June 30, 2022 | -8.34M |
| March 31, 2022 | -6.779M |
| December 31, 2021 | -5.218M |
| September 30, 2021 | -8.694M |
| June 30, 2021 | -9.076M |
| March 31, 2021 | -6.452M |
| December 31, 2020 | -2.48M |
| September 30, 2020 | -4.335M |
| June 30, 2020 | -2.198M |
| March 31, 2020 | -4.461M |
| December 31, 2019 | -3.414M |
| September 30, 2019 | -3.072M |
| June 30, 2019 | -3.841M |
| March 31, 2019 | -4.889M |
| December 31, 2018 | -3.541M |
| September 30, 2018 | -2.981M |
| June 30, 2018 | -1.868M |
| March 31, 2018 | -2.233M |
| Date | Value |
|---|---|
| December 31, 2017 | -3.623M |
| September 30, 2017 | -5.455M |
| June 30, 2017 | -0.018M |
| March 31, 2017 | -0.011M |
| December 31, 2016 | 22.50M |
| September 30, 2016 | -7.263M |
| June 30, 2016 | -6.354M |
| March 31, 2016 | -9.087M |
| December 31, 2015 | -10.68M |
| September 30, 2015 | -8.632M |
| June 30, 2015 | 16.66M |
| March 31, 2015 | -6.444M |
| December 31, 2014 | -6.944M |
| September 30, 2014 | -5.76M |
| June 30, 2014 | -2.912M |
| March 31, 2014 | -1.692M |
| December 31, 2013 | -7.538M |
| September 30, 2013 | -10.23M |
| June 30, 2013 | -7.467M |
| March 31, 2013 | -10.69M |
| December 31, 2012 | -9.497M |
| September 30, 2012 | -12.94M |
| June 30, 2012 | -13.68M |
| March 31, 2012 | -7.383M |
| December 31, 2011 | -4.44M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-11.31M
Minimum
Sep 2022
-2.198M
Maximum
Jun 2020
-6.029M
Average
-5.253M
Median
Cash from Operations (Quarterly) Benchmarks
| Accelerate Diagnostics Inc | -8.452M |
| Atossa Therapeutics Inc | -4.698M |
| ENDRA Life Sciences Inc | -2.144M |
| Perspective Therapeutics Inc | 13.85M |
| Electromed Inc | 1.351M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | 56.11M |
| Free Cash Flow | -21.46M |
| Free Cash Flow Per Share (Quarterly) | -0.2111 |
| Free Cash Flow Yield | -19.29% |